chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10 hours after injection strong pain in the left arm.   Lasted 3 days. fever, chills 2nd night, low grade fever.  lasted about 8 hours then ceased. General tiredness for 2-3 days
This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Vaccination Symptoms) and PYREXIA (body temperature increase up to 37.5 degrees C after injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination Symptoms) and PYREXIA (body temperature increase up to 37.5 degrees C after injection). At the time of the report, VACCINATION COMPLICATION (Vaccination Symptoms) and PYREXIA (body temperature increase up to 37.5 degrees C after injection) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 37.5 degrees C (High) temperature increase up to 37.5 degrees C after injection. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant Drug details were reported. No Treatment information was provided.
Information has been received from a medical assistant referring to a 4 month old female patient. No relevant medical history or concurrent conditions were reported. On 22-JUN-2015, the patient was inadvertently vaccinated with improperly stored ROTATEQ (lot # K014826, expiration date 28-MAY-2016; dose was not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Original report is MARRS#1507USA011322. Additional information has been requested.
adverse reactions consistent with both doses; Painful; smell dulled; Sense of taste altered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reactions consistent with both doses), PAIN (Painful), HYPOSMIA (smell dulled) and TASTE DISORDER (Sense of taste altered) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis since 01-Jan-2010, Hay fever, Grass allergy (Itchiness, redness, swelling at exposure site.) since 10-Nov-1961, Diabetes (Pre Diabetes) since 01-Jan-2019, Depression since 01-Dec-2020 and Allergy since 01-Jan-2010. Concomitant products included LORATADINE (CLARITINE) for Allergy, SERTRALINE HYDROCHLORIDE (ZOLOFT) from 01-Dec-2020 to an unknown date for Depression, METFORMIN from 01-Jan-2010 to an unknown date for Diabetes, RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) from 02-Feb-2019 to an unknown date for Psoriasis.   On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reactions consistent with both doses), PAIN (Painful), HYPOSMIA (smell dulled) and TASTE DISORDER (Sense of taste altered). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency; IBUPROFEN for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 10-Sep-2021, HYPOSMIA (smell dulled) and TASTE DISORDER (Sense of taste altered) had resolved with sequelae. At the time of the report, VACCINATION COMPLICATION (adverse reactions consistent with both doses) and PAIN (Painful) outcome was unknown.            Treatment information include lot's of fluids and chicken soup. Patient had stated that he never had a reaction to the vaccine before and pharmacist has suggested to go to the ER, but did not seen physician.   This case was linked to MOD-2021-278767 (Patient Link).
Patient came in with red swollen right arm from the vaccine 2 days ago. Symptoms started 1 day ago. Patient did not take any medications regarding the reaction. Patient was advised to go to ER.
After receiving immunization patient reported a tingling and burning sensation in her hand. This persisted for 24 hours.
Vaccines administered between 1:30-2:00pm in patient's home. Pharmacist stayed to conduct comprehensive medication review. At 3:30pm, patient reported to pharmacist that she had been feeling really itchy, and was starting to feel her tongue and lip swelling. Patient called aide, who called patient's primary care office - Visiting Physicians. As aide called back (around 3:40pm), patient told pharmacist she was starting to feel short of breath.  Pharmacist administered 1 dose of epinephrine (0.3mg/0.3ml), and called 911. (Aide was calling to say that primary care office had also advised epinephrine administration.)  911 operator dispatched EMS, and advised to administer 2nd dose of epinephrine if patient worsened. After hanging up with 911 operator, patient said her breathing was getting worse, and had to search for the word "shallow" to describe her breathing. Pharmacist administered 2nd dose of epinephrine at 3:52pm, EMS arrived by 3:55pm. Pharmacist provided med list from med review to EMS, as well as finding and providing patient's Dexcom sensor.
Arm pain, flu like symptoms (chills, body aches, nausea) lasting for approximately 24 hours.
horrible headache; felt really bad; 102 fever; achy; fatigued; This is a spontaneous report from a contactable other health professional reporting for herself. A 60-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 12Jan2021 11:15 AM, at a single dose on the left arm for COVID-19 immunization. The vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at time of vaccination. Medical history included known allergies to penicillin and COVID. The patient had COVID prior to vaccination. Concomitant medications included lisinopril and escitalopram; these are the other medications the patient received in two weeks. The patient previously took betadine and experienced allergies. On 13Jan2021 02:30 AM (as reported), the patient experienced a horrible headache, felt really bad, 102 fever, achy, and fatigued. The patient woke up at about 2:30 am and had a horrible headache. Got out of bed at 4:30 and felt really bad. She had 102 fever. She was still running 100 at 5:42 pm. She was achy, still have a headache and am very fatigued at the time of report. She asked if she can take something for the fever and headache. The patient was not tested for COVID post vaccination. The patient did not receive any treatment for the reported adverse events. Outcome of the events was not recovered.  Information on the Lot/Batch number has been requested.
After my 1st dose?..I experienced severe arm pain at shot for several days. Headache within 4 hours from getting the shot which continued for up to two days after. Sore throat. Chest tightness and heart beating fast a few days after shot. Today is almost a week after getting first dose and I still feel off. Lightheaded now and them. Throat still killing me. Chest still feels like it has  pressure . Not sure what is going on but after this one shot and I had reaction like this?.not sure I?ll get the 2nd dose.
Swelling and redness at injection site, sore, itchy and aches from shoulder joint to elbow, started ~ 12 hours after injection and continues 40 hours later, not resolved.
After getting booster on 11/3/21, pain persisted in upper arm, shoulder and elbow and continues to this date. SIRVA is what I read about online and only 30% supposedly make full recovery from the pain. Range of motion seems to be ok but I cannot sleep through the night from the throbbing pain in my left arm. It said if injection is not given in proper muscle this can happen and I don?t want this to happen to others if administered to them by the same person who did mine.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 25-APR-2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The vaccine "did" function as intended [considered to mean the vaccine did not function as intended], and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 21-MAR-2016, the patient was treated by a physician's assistant and a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was treated with gabapentin, ATARAX, and VALTREX for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
As  soon  As  needle WAS retracted , blood squirted out and  injection site started to swell up and  become hard; upon MASSAGing, rubbing site it  did soften up  but still slightly swollen; advised pt  to cont to rub, ice & contact MD & pharRmacy if condition got worse . Did have pt wait in  pharmacy waiting/vaccination area for 15-20min before leaving
Muscle soreness, edema, rash left upper arm, diagnosis- upper arm cellulitis, left
Complained of swelling, warmth, pain in left arm from shoulder to elbow complained of generalized aching in arm.
Patient reports lightheadedness, sweating, and dizziness ~2 minutes after receiving vaccine.  He reports history of similar reactions to vaccines, blood draws, etc.  He denies changes in vision or hearing.  He denies trouble breathing, chest pain, rash.  He was transported by wheelchair to medical observation unit at 6:00pm.  He was already starting to feel better on arrival to medical observation unit.  He was released at 6:35 to drive himself home.   He reported complete resolution of symptoms upon discharge.   Vitals as follows:  6:04pm- HR- 69, BP- 112/72, SPO2- 99 6:35 (sitting)- HR- 68, BP- 110/70 6:40 (standing)- HR- 68, BP- 112/70
No known adverse event - pt did not get the correct dose for her age. Instead, she got a dose for her 1st and 2nd shots from Pfizer orange cap (pediatric vials).
On the morning of September 7, I was awakened by a severe sore throat, terrible runny nose, body aches, a cough, fatigue, and a slight headache. I thought a cold was coming on. My temperature was 99.4. That evening I took 2 500 mg. TYLENOL for the body aches. The next day, 9/8 the symptoms worsened and I did an iHealth 15 minute Covid antigen test which was positive. On Friday, 9/9  I phoned Dr. because my symptoms were the same as the day before. He prescribed PAXLOVID which I began that evening and did the five full days of the medication. On Sat. 9/10 I was noticeably better with all the symptoms which rapidly improved so that on Wed. 9/14 I tested negative for Covid with iHealth. That Sunday, 9/18, I resumed my usual activities and ran 5 miles refereeing soccer games.
No additional AE; Caller reported that M-M-R II, ROTATEQ and VAQTA that underwent temperature excursions were administered. No further information was provided. No additional AE. No PQC.   ?    Names of vaccines involved (including lot/exp): M-M-R II LOT: T029550 EX; This spontaneous report was received from Pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On 20-MAY-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, lot #T029550, expiration date: 01-SEP-2022, administered for prophylaxis (strength, dose, route of administration, and anatomical location were not provided).  The vaccine was stored at the temperature that was reported as above 46 degrees of Fahrenheit (46.9 F) for 25 minutes. There was a previous temperature excursion reported: above 46 degrees of Fahrenheit (47.2 F) for 25 minutes.  No additional adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2206USA005639: US-009507513-2206USA005640: US-009507513-2206USA006596: US-009507513-2206USA006597: US-009507513-2206USA006598: US-009507513-2206USA006599: US-009507513-2206USA000873:
1st dose received 1/8/2021. 2nd dose received 1/27/2021. In February, I had an herpes simplex virus outbreak on the face (mouth and nose).  I have continued to have no outbreaks of HSV on mouth and nose about every 3 weeks since my 2nd dose (approximately). Was prescribed acyclovir to treat.
Vomiting; Phlegm; Headache; Dizziness; This is a spontaneous report from a contactable consumer (patient).   This 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number unknown), via an unspecified route of administration at single dose in the left arm on 20Jan2021 14:00 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took hydrocodone and experienced drug allergy. On 20Jan2021 15:00, the patient experienced vomiting, phlegm, headache, dizziness. No treatment required. The outcome of  the events was recovered on an unspecified date in Jan2021.The patient had not had symptoms associated with COVID-19 prior vaccination. The patient had not been tested for COVID-19 post the vaccination. The patient was not pregnant at the time of vaccination.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
- headache, mild fever, brain fog, dizziness on 4/11 - on 4/13 admitted with intractable dizziness and continued brain fog (requiring questions to be asked multiple times to answer. Taking a long time to remember current year and month) - still dizzy on discharge and unable to drive or work
My son received his vaccinations and passed out in the lobby of the doctors office as we were leaving. He hit his head on the cement floor and had to be taken to the ER.
Pt noticed soreness, redness, and swelling of arm this am while dressing. Noticed few whelps around site also. Insisted pt to apply ice pack x 15 minutes Q20 PRN Benadryl 25-50 mg by PO now. Call 911 if develops wheezing or SOB
Pt recvd Engerix-B & p/1st dose, devel fibromyalgia;
site of injection is all red; little bit swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (site of injection is all red) and VACCINATION SITE SWELLING (little bit swollen) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (site of injection is all red) and VACCINATION SITE SWELLING (little bit swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (site of injection is all red) and VACCINATION SITE SWELLING (little bit swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Reporter did not allow further contact
Case PHEH2016US023366 is an initial spontaneous report received from nurse on 13 Sep 2016. This case refers to 46 years old patient of an unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: 1515701, expiry date: not reported) at a dose of 0.5 ml intramuscularly into left arm on 01 Dec 2015. It was reported that, the patient received FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion and it was administered to unknown number of patients. No adverse event was reported following this medication error.
I95.9 HYPOTENSION 9/23/2022 HYPOTENSION
allergy to PEG in Covid vaccine/ experienced 3 weeks of severe allergic reaction after each dose of the covid vaccine; This is a spontaneous report from a contactable consumer (patient) via medical information team . This consumer reported similar events for two patients (including self). This is first of two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified dates  as dose 1, single and dose 2, single (Lot number and Expiry date was not reported) for covid-19 immunization. This vaccine contains Polyethylene Glycol (PEG). The patient medical history and concomitant medications were not reported.  The patient experienced allergy to PEG in covid vaccine/ experienced 3 weeks of severe allergic reaction after each dose of the covid vaccine on an unspecified dates. It was reported, patient was since been diagnosed with PEG allergy. Treatment for the event was not reported. The outcome for the event was unknown.  The lot number for the BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101137872 same reporter, drug, event/ different patient
No additional adverse effect reported; vaccine that underwent a temperature excursion was administered; Information has been received from a medical assistant concerning a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, concomitant medications, or drug reactions/allergies.    It was reported that hepatitis a vaccine, inactivated (VAQTA) (lot # T013205, expiration date was reported as 02-DEC-2021 but upon internal validation established as 03-DEC-2021; lot # T023913, expiration date was reported as 30-MAR-2022 but upon internal validation established as 31-MAR-2022; lot # T018229, expiration date was reported as 13-DEC-2021 but upon internal validation established as 14-DEC-2021) underwent a temperature excursion. On 07-JUN-2021, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) (dose and route were not reported) for prophylaxis. Information for which lots were given to patient not provided. The vaccine was exposed the temperature excursion above 46 Fahrenheit degrees (47.2 Fahrenheit degrees) for 52 minutes (product storage error). The data logger was involved. There was no previous temperature excursion. No adverse effects were reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T013205; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability; Sender's Comments:  US-009507513-2106USA004356:
Myalgia Narrative: Heavy left upper extremity with soreness days 1 & w after injection with numbness and tingling at tips of fingers, hands and feet continuing after2 weeks. States it is getting worse.
All syptoms occur at vaccination site.  Swollen itchy rash, area hot to touch.
Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion; Administered vaccine from vials that may have been compromised; This spontaneous case was reported by a health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021 at 2:27 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Mar-2021 at 2:27 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of the patient was reported as 69.59.  No concomitant medications were reported.  Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature 35 to 51 degrees Fahrenheit from 09:00 aM to 01:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 03-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a brand traceable temperature monitor at every hour.   Treatment medications were not reported
rash on other arm; rash on abdomen/rash on upper thighs; rash on arm at injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site). At the time of the report, RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.